Tempest Therapeutics, Inc. Operating Lease, Expense
Tempest Therapeutics, Inc. (TPST) reported Operating Lease, Expense of $200.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-05-13
- Tempest Therapeutics, Inc. operating lease, expense for the quarter ending 2021-03-31 was $200.00K, a 0.00% change year-over-year.
- Tempest Therapeutics, Inc. operating lease, expense for the quarter ending 2020-12-31 was $200.00K, a 33.33% decline year-over-year.
- Tempest Therapeutics, Inc. operating lease, expense for the quarter ending 2020-09-30 was $200.00K, a 0.00% change year-over-year.
- Tempest Therapeutics, Inc. operating lease, expense for the quarter ending 2020-06-30 was $200.00K, a 100.00% increase year-over-year.
- Tempest Therapeutics, Inc. operating lease, expense for fiscal 2020 was $900.00K, a 28.57% increase from fiscal 2019.
- Tempest Therapeutics, Inc. operating lease, expense for fiscal 2019 was $700.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-13 | $400.00K derived: sum of 2 quarters · filed 2021-05-13 | $600.00K derived: sum of 3 quarters · filed 2021-05-13 | $800.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $400.00K derived: sum of 2 quarters · filed 2021-03-29 | $600.00K derived: sum of 3 quarters · filed 2021-03-29 | $900.00K 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-09 | $400.00K derived: sum of 2 quarters · filed 2020-11-09 | $700.00K 10-Q · filed 2020-11-09 | $900.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-06-30 | $200.00K 10-Q · filed 2020-08-10 | $500.00K 10-Q · filed 2020-08-10 | $700.00K derived: sum of 3 quarters · filed 2021-05-13 | $900.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-13 | $231.00K 10-Q · filed 2020-05-08 | $500.00K derived: sum of 2 quarters · filed 2021-05-13 | $700.00K derived: sum of 3 quarters · filed 2021-05-13 | $800.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $500.00K derived: sum of 2 quarters · filed 2021-03-29 | $600.00K derived: sum of 3 quarters · filed 2021-03-29 | $700.00K 10-K · filed 2021-03-29 | |||
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-09 | $233.00K 10-Q · filed 2019-11-13 | $300.00K derived: sum of 2 quarters · filed 2020-11-09 | $400.00K 10-Q · filed 2020-11-09 | $456.00K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-10 | $156.00K 10-Q · filed 2019-08-12 | $200.00K 10-Q · filed 2020-08-10 | $223.00K 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | $67.00K 10-Q · filed 2020-05-08 | ||||||
| 2018-09-30 | $48.00K 10-Q · filed 2019-11-13 | $94.00K derived: sum of 2 quarters · filed 2019-11-13 | $142.00K 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | $46.00K 10-Q · filed 2019-08-12 | $94.00K 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | $48.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |